RhumbLine Advisers
ALHC icon

RhumbLine Advisers’s Alignment Healthcare ALHC Stock Holding History

RhumbLine Advisers’s Portfolio ALHC Stock Details ALHC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$3.85M Buy
218,505
+19,775
+10% +$397K ﹤0.01% 1528
2025
Q4 		$3.92M Sell
198,730
-1,335
-0.7% -$24K ﹤0.01% 1526
2025
Q3 		$3.49M Buy
200,065
+15,382
+8% +$228K ﹤0.01% 1605
2025
Q2 		$2.59M Buy
184,683
+43,045
+30% +$693K ﹤0.01% 1749
2025
Q1 		$2.64M Buy
141,638
+5,934
+4% +$88.5K ﹤0.01% 1677
2024
Q4 		$1.53M Buy
135,704
+2,937
+2% +$34.3K ﹤0.01% 2026
2024
Q3 		$1.57M Sell
132,767
-4,529
-3% -$42.8K ﹤0.01% 2032
2024
Q2 		$1.07M Buy
137,296
+16,083
+13% +$105K ﹤0.01% 2202
2024
Q1 		$601K Buy
121,213
+2,733
+2% +$17.5K ﹤0.01% 2547
2023
Q4 		$1.02M Sell
118,480
-1,305
-1% -$9.54K ﹤0.01% 2238
2023
Q3 		$831K Sell
119,785
-2,040
-2% -$12.3K ﹤0.01% 2309
2023
Q2 		$700K Sell
121,825
-6,536
-5% -$42.3K ﹤0.01% 2487
2023
Q1 		$816K Buy
128,361
+8,598
+7% +$82K ﹤0.01% 2220
2022
Q4 		$1.41M Buy
119,763
+14,574
+14% +$177K ﹤0.01% 1965
2022
Q3 		$1.25M Buy
105,189
+9,275
+10% +$135K ﹤0.01% 2024
2022
Q2 		$1.09M Buy
95,914
+17,565
+22% +$185K ﹤0.01% 2093
2022
Q1 		$880K Buy
78,349
+9,042
+13% +$81.4K ﹤0.01% 2178
2021
Q4 		$974K Buy
69,307
+47,520
+218% +$832K ﹤0.01% 2224
2021
Q3 		$348K Buy
21,787
+1,225
+6% +$23.7K ﹤0.01% 2702
2021
Q2 		$481K Buy
+20,562
New +$500K ﹤0.01% 2581

Other funds holding ALHC

Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
HRCM
Hood River Capital Management Palm Beach Gardens, Florida $9.98B AUM 145.42% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

RhumbLine Advisers's ALHC Position: Q1 2026 in Review

RhumbLine Advisers increased its Alignment Healthcare (ALHC) stake by 10% in Q1 2026, buying an estimated $397K and bringing the position to 218,505 shares worth $3.85M. The position accounts for ﹤0.01% of the portfolio, ranked #1528.

RhumbLine Advisers first reported a position in ALHC in Q2 2021 and has held it in 20 quarters since. The position peaked at $3.92M in Q4 2025. 293 funds tracked by Wall St. Rank hold ALHC as of Q1 2026.

  • RhumbLine Advisers held 218,505 shares of Alignment Healthcare worth $3.85M as of Q1 2026.
  • RhumbLine Advisers bought 19,775 Alignment Healthcare shares in Q1 2026, an estimated $397K.
  • Alignment Healthcare made up ﹤0.01% of RhumbLine Advisers's portfolio in Q1 2026, its #1528 holding.
  • RhumbLine Advisers first reported a position in Alignment Healthcare in Q2 2021 and has held it in 20 quarters since.
  • RhumbLine Advisers's Alignment Healthcare position peaked at $3.92M in Q4 2025.
  • 293 funds tracked by Wall St. Rank held Alignment Healthcare as of Q1 2026.

Based on RhumbLine Advisers's 13F filing for Q1 2026, filed 12 May 2026.